Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10810 | 31177662 | Zhonghua Gan Zang Bing Za Zhi | [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease]. | 2019 | Details |
| A10813 | 31176759 | Mol Cell Endocrinol | Adiponectin is required for pioglitazone-induced improvements in hepatic steatosis in mice fed a high-fat diet. | 2019 | Details |
| A10824 | 32812939 | Metabol Open | Nonalcoholic fatty liver disease in obese adolescent females is associated with multi-tissue insulin resistance and visceral adiposity markers. | 2019 | Details |
| A10835 | 31165837 | Food Funct | Sinapine reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota. | 2019 | Details |
| A10839 | 31163711 | Medicina (Kaunas) | A Simple Index for Nonalcoholic Steatohepatitis-HUFA-Based on Routinely Performed Blood Tests. | 2019 | Details |
| A10840 | 31163617 | Int J Mol Sci | Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. | 2019 | Details |
| A10842 | 31162803 | Liver Int | Association between nut consumption and non-alcoholic fatty liver disease in adults. | 2019 | Details |
| A10853 | 31155826 | Liver Int | Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study. | 2019 | Details |
| A10858 | 31153607 | Med Clin (Barc) | Relationship between hypothyroidism and non-alcoholic fatty liver disease in the Spanish population. | 2019 | Details |
| A10859 | 31153588 | Acta Histochem | A histomorphometric study on the hepatoprotective effects of a green rooibos extract in a diet-induced obese rat model. | 2019 | Details |
| A10863 | 31151875 | Ann Hepatol | Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population. | 2019 | Details |
| A10870 | 32818162 | Curr Opin Physiol | Redox Regulation of Metabolic Syndrome: Recent Developments in Skeletal Muscle Insulin Resistance and Non-alcoholic Fatty Liver Disease (NAFLD). | 2019 | Details |
| A10874 | 31145699 | JCI Insight | A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans. | 2019 | Details |
| A10876 | 31144451 | J Cell Mol Med | Alisol A attenuates high-fat-diet-induced obesity and metabolic disorders via the AMPK/ACC/SREBP-1c pathway. | 2019 | Details |
| A10878 | 31144261 | Curr Obes Rep | Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized Obesity. | 2019 | Details |
| A10884 | 31141077 | Arq Gastroenterol | THE CORRELATION OF NECK CIRCUMFERENCE AND INSULIN RESISTANCE IN NAFLD PATIENTS. | 2019 | Details |
| A10891 | 31137547 | Medicina (Kaunas) | Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10894 | 31136662 | Am J Clin Nutr | Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial. | 2019 | Details |
| A10905 | 31131845 | Clin Infect Dis | Natural Course of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Patients With Human Immunodeficiency Virus With and Without Combination Antiretroviral Therapy-associated Lipodystrophy: A 16-Year Follow-up Study. | 2020 | Details |
| A10907 | 31131153 | Am J Cardiovasc Dis | Ramipril significantly attenuates the development of non-alcoholic steatohepatitis in hyperlipidaemic rabbits. | 2019 | Details |
| A10913 | 31127561 | Methods Mol Biol | Application of Stable Isotope Labels for Metabolomics in Studies in Fatty Liver Disease. | 2019 | Details |
| A10915 | 31126574 | Complement Ther Med | Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trial. | 2019 | Details |
| A10918 | 31124886 | J Pediatr Gastroenterol Nutr | Psychotropic Medications Are Associated With Increased Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10919 | 31124558 | Am J Clin Nutr | Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. | 2019 | Details |
| A10931 | 31115369 | Indian J Med Res | Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern. | 2019 | Details |
| A10945 | 31110049 | J Lipid Res | FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice. | 2019 | Details |
| A10946 | 31109939 | Diabetes | The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism. | 2019 | Details |
| A10960 | 31101783 | Georgian Med News | RESULTS OF CORRECTION OF THE HEPATIC STEATOSIS ON THE BACKGROUND OF HYPERTENSION AND OVERWEIGHT WITH HELP OF ESSENTIAL PHOSPHOLIPID COMPLEX. | 2019 | Details |
| A10969 | 31098621 | Endocr Rev | The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance. | 2019 | Details |
| A10973 | 31097179 | Maturitas | Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity. | 2019 | Details |
| A10978 | 31094181 | Ter Arkh | Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy. | 2019 | Details |
| A10982 | 31093446 | Food Sci Biotechnol | Green satsuma mandarin orange (Citrus unshiu) extract reduces adiposity and induces uncoupling protein expression in skeletal muscle of obese mice. | 2018 | Details |
| A10990 | 31089474 | J Diabetes Res | Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link? | 2019 | Details |
| A10993 | 31088856 | Diabetes | Liver Function and Risk of Type 2 Diabetes: Bidirectional Mendelian Randomization Study. | 2019 | Details |
| A11009 | 31082855 | Clin Transl Gastroenterol | Serum Soluble Receptor for AGE (sRAGE) Levels Are Associated With Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11010 | 31082799 | J Endocrinol | Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis. | 2019 | Details |
| A11014 | 31081822 | J Vis Exp | An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes. | 2019 | Details |
| A11036 | 31075051 | J Am Coll Nutr | Circulating ALT Levels in Healthy Volunteers Over Life-Span: Assessing Aging Paradox and Nutritional Implications. | 2019 | Details |
| A11037 | 31074909 | J Bone Miner Res | Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution. | 2019 | Details |
| A11043 | 31071311 | Metabolism | Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement. | 2019 | Details |
| A11048 | 31069057 | F1000Res | Recent advances in the understanding and management of polycystic ovary syndrome. | 2019 | Details |
| A11054 | 31064654 | Biochem Biophys Res Commun | IDH2 protects against nonalcoholic steatohepatitis by alleviating dyslipidemia regulated by oxidative stress. | 2019 | Details |
| A11058 | 31063974 | Endocr Connect | Elevated serum neuregulin 4 levels in patients with hyperthyroidism. | 2019 | Details |
| A11096 | 31044315 | Curr Diab Rep | Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11107 | 31039348 | Exp Cell Res | Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1α-HO-1-PGC1α-mitochondrial signaling. | 2019 | Details |
| A11113 | 31035998 | BMC Med | Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity. | 2019 | Details |
| A11115 | 31035507 | Nutrients | Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese Rats. | 2019 | Details |
| A11117 | 31034714 | Mol Nutr Food Res | Pear Extract and Malaxinic Acid Reverse Obesity, Adipose Tissue Inflammation, and Hepatosteatosis in Mice. | 2019 | Details |
| A11139 | 31025557 | Adv Clin Exp Med | Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study. | 2019 | Details |
| A11145 | 31024199 | J Clin Exp Hepatol | Clinical, anthropometric, biochemical and histological character of nonalcoholic fatty liver disease without Insulin Resistance. | 2018 | Details |
| A11154 | 31020720 | Exp Physiol | Combined treatment of dipeptidyl peptidase-4 inhibitor and exercise training improves lipid profile in KK/Ta mice. | 2019 | Details |
| A11155 | 31019719 | Glob Health Epidemiol Genom | Non-alcoholic fatty liver disease in Africa: a hidden danger. | 2019 | Details |
| A11156 | 31019294 | Lab Invest | Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages. | 2019 | Details |
| A11167 | 31013265 | Med Sci Monit | Transcriptional Regulation of Early Growth Response Gene-1 (EGR1) is Associated with Progression of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients with Insulin Resistance. | 2019 | Details |
| A11174 | 31011258 | World J Gastroenterol | Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients. | 2019 | Details |
| A11177 | 31010049 | Int J Mol Sci | Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. | 2019 | Details |
| A11181 | 31009401 | Eur J Gastroenterol Hepatol | The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis. | 2019 | Details |
| A11183 | 31008924 | Medicine (Baltimore) | Metabolic characteristics of obese children with fatty liver: A STROBE-compliant article. | 2019 | Details |
| A11186 | 31007691 | J Res Med Sci | A randomized controlled trial comparing effects of a low-energy diet with n-3 polyunsaturated fatty acid supplementation in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11188 | 31007045 | Antioxid Redox Signal | Peroxiredoxin 6 Confers Protection Against Nonalcoholic Fatty Liver Disease Through Maintaining Mitochondrial Function. | 2019 | Details |
| A11192 | 31004828 | Cell Mol Gastroenterol Hepatol | Metabolic Targets in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11195 | 31004566 | Biochem Pharmacol | Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase/sphingoine-1-phosphate pathway, and TLR4 receptors. | 2019 | Details |
| A11209 | 30998190 | Ann Biol Clin (Paris) | [Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker]. | 2019 | Details |
| A11211 | 30995640 | Med Princ Pract | Serum Adropin Levels Are Reduced in Adult Patients with Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11224 | 30987010 | J Clin Med | Utility of ALT Concentration in Men and Women with Nonalcoholic Fatty Liver Disease: Cohort Study. | 2019 | Details |
| A11250 | 30973968 | Br J Clin Pharmacol | Hepatic exposure of metformin in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11264 | 30969285 | Food Funct | Systematic investigation of the mechanism of Cichorium glandulosum on type 2 diabetes mellitus accompanied with non-alcoholic fatty liver rats. | 2019 | Details |
| A11265 | 30968772 | Curr Med Chem | Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A11270 | 30965331 | Ann Nutr Metab | Fetuin-B Links Nonalcoholic Fatty Liver Disease to Chronic Kidney Disease in Obese Chinese Adults: A Cross-Sectional Study. | 2019 | Details |
| A11273 | 30964704 | Am J Physiol Endocrinol Metab | Role of exercise-induced hepatokines in metabolic disorders. | 2019 | Details |
| A11277 | 30962478 | Nat Commun | Hepatic arginase 2 (Arg2) is sufficient to convey the therapeutic metabolic effects of fasting. | 2019 | Details |
| A11280 | 30959577 | Hepatology | Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress. | 2019 | Details |
| A11286 | 30957185 | Mol Med Rep | Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA‑treated HepG2 cells. | 2019 | Details |
| A11290 | 30953079 | J Mol Med (Berl) | Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology. | 2019 | Details |
| A11292 | 30952479 | J Formos Med Assoc | Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis. | 2019 | Details |
| A11294 | 30951517 | Am J Gastroenterol | An AGTR1 Variant Worsens Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome. | 2019 | Details |
| A11304 | 30947882 | Clin Liver Dis | Obstructive Sleep Apnea and the Liver. | 2019 | Details |
| A11307 | 30945694 | J Genet | Genetics of nonalcoholic fatty liver disease in Asian populations. | 2019 | Details |
| A11310 | 30945129 | Curr Obes Rep | Nonalcoholic Fatty Liver Disease and Obesity Treatment. | 2019 | Details |
| A11315 | 30942551 | Obesity (Silver Spring) | Comparison of Abdominal Obesity and Fatty Liver and Their Association with Insulin Resistance and Metabolic Syndrome in Chinese Adults. | 2019 | Details |
| A11318 | 30940491 | Nutr Metab Cardiovasc Dis | Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese. | 2019 | Details |
| A11320 | 30939889 | Rev Esp Enferm Dig | Psoriasis and fatty liver: a harmful synergy. | 2019 | Details |
| A11326 | 30936733 | Diabetes Metab Syndr Obes | Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease. | 2019 | Details |
| A11327 | 30936549 | Nat Med | Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. | 2019 | Details |
| A11346 | 30928918 | BMJ Open | Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials. | 2019 | Details |
| A11347 | 30928418 | Dig Liver Dis | Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11363 | 30921653 | Adv Med Sci | Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children? | 2019 | Details |
| A11366 | 30920583 | Endocr Rev | The Liver-α-Cell Axis and Type 2 Diabetes. | 2019 | Details |
| A11368 | 30920415 | Am J Gastroenterol | Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation. | 2019 | Details |
| A11377 | 30918952 | Inflamm Bowel Dis | Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. | 2019 | Details |
| A11378 | 30918873 | J Diabetes Metab Disord | Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity. | 2018 | Details |
| A11380 | 30918325 | Lab Invest | Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease. | 2019 | Details |
| A11384 | 30917546 | Nutrients | Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids. | 2019 | Details |
| A11393 | 30915402 | Clin Exp Hepatol | Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children. | 2019 | Details |
| A11394 | 30915401 | Clin Exp Hepatol | Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease. | 2019 | Details |
| A11396 | 30914267 | J Hepatol | Macrophage p38α promotes nutritional steatohepatitis through M1 polarization. | 2019 | Details |
| A11398 | 30912854 | Hepatology | Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD. | 2019 | Details |
| A11399 | 30912337 | Endocrinol Metab (Seoul) | Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases. | 2019 | Details |
| A11403 | 30909521 | Cells | A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver. | 2019 | Details |
| A11414 | 30905208 | Expert Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease. | 2019 | Details |